Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: EITR BIOLOGICS, INC.
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2024-07-01 to 2025-06-30
Current total value of award: $499896.06
Description: DEVELOP A NOVEL ODIN THERAPEUTIC MEDICAL COUNTERMEASURE CAPABLE OF PROTECTING AGAINST PNEUMONIC UNENCAPSULATED Y. PESTIS.